Biohaven (BHVN) analyst forecast and price target
Analyst forecast
Consensus of 14 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Neutral | $10.00 | Sep 10, 2026 |
| RBC Capital | Downgraded | Outperform → Sector Perform | $19.00 from $23.00 | Sep 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $19.00 from $18.00 | Aug 12, 2026 |
| RBC Capital | Maintained | Outperform | $23.00 from $22.00 | Aug 11, 2026 |
| B of A Securities | Downgraded | Neutral → Underperform | $11.00 from $12.00 | Jun 29, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $10.00 | May 26, 2026 |
| Morgan Stanley | Maintained | Overweight | $18.00 from $21.00 | May 13, 2026 |
| RBC Capital | Maintained | Outperform | $22.00 from $23.00 | May 5, 2026 |
| Citigroup | Maintained | Buy | $17.00 from $14.00 | Apr 2, 2026 |
| TD Cowen | Maintained | Buy | $30.00 from $15.00 | Mar 11, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $10.00 from $11.00 | Mar 4, 2026 |
| RBC Capital | Maintained | Outperform | $23.00 from $22.00 | Mar 3, 2026 |
| RBC Capital | Upgraded | Sector Perform → Outperform | $22.00 from $9.00 | Jan 21, 2026 |
| Morgan Stanley | Maintained | Overweight | $21.00 from $26.00 | Jan 6, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $11.00 | Dec 26, 2025 |
| HC Wainwright & Co. | Downgraded | Buy → Neutral | $11.00 from $30.00 | Dec 3, 2025 |
| UBS | Downgraded | Buy → Neutral | $11.00 from $26.00 | Nov 26, 2025 |
| JP Morgan | Maintained | Overweight | $15.00 from $47.00 | Nov 20, 2025 |
| BTIG | Maintained | Buy | $16.00 | Nov 18, 2025 |
| Morgan Stanley | Maintained | Overweight | $26.00 from $54.00 | Nov 18, 2025 |
Frequently asked questions
What is the price target for BHVN stock?
The average 12-month analyst price target for Biohaven (BHVN) is $16.00, with a high estimate of $19.00 and a low of $10.00, across 3 analysts.
Is BHVN a buy, sell, or hold?
Analysts covering Biohaven currently average a Buy rating: 10 buy, 3 hold and 1 sell, from 14 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for BHVN?
The average price target of $16.00 implies 40.04% upside from the last price of $11.43.
What is the latest analyst rating on BHVN?
On Sep 10, 2026, HC Wainwright & Co. maintained Biohaven at Neutral with a price target of $10.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.